🚨Multiple Studies Confirm Ivermectin, Fenbendazole & Mushrooms...
Nicolas Hulscher, MPH@NicHulscher
56 views
Oct 14, 2025
~1 min read
Advertisement
1
🚨Multiple Studies Confirm Ivermectin, Fenbendazole & Mushrooms Exhibit Potent Anti-Cancer Activity via 20+ Mechanisms
💠Ivermectin:
✅ Widespread anecdotal reports of remission
✅ 14 distinct anticancer mechanisms (systematic review)
✅ Targets glioblastoma, leukemia, ovarian, cervical cancers & more
✅ Proven safe—even with chemo
💠Fenbendazole:
✅ Linked to remission of Stage IV cancers (Makis et al)
✅ Strong safety profile in humans
✅ Disrupts tumor metabolism & growth pathways
💠Medicinal Mushrooms (Cordyceps, Turkey Tail, Reishi):
✅ Boost NK & T cells
✅ Block angiogenesis
✅ Trigger apoptosis
✅ ↓ cancer risk by 34% (meta-analysis)
✅ ↑ survival & QoL (39 clinical trials)
It’s time for cancer therapies that HEAL the body—not destroy it.
💠Ivermectin:
✅ Widespread anecdotal reports of remission
✅ 14 distinct anticancer mechanisms (systematic review)
✅ Targets glioblastoma, leukemia, ovarian, cervical cancers & more
✅ Proven safe—even with chemo
💠Fenbendazole:
✅ Linked to remission of Stage IV cancers (Makis et al)
✅ Strong safety profile in humans
✅ Disrupts tumor metabolism & growth pathways
💠Medicinal Mushrooms (Cordyceps, Turkey Tail, Reishi):
✅ Boost NK & T cells
✅ Block angiogenesis
✅ Trigger apoptosis
✅ ↓ cancer risk by 34% (meta-analysis)
✅ ↑ survival & QoL (39 clinical trials)
It’s time for cancer therapies that HEAL the body—not destroy it.
1:21
Nicolas Hulscher, MPH@NicHulscher
🚨BREAKING STUDY: Intranasal Nano-Ivermectin Shrinks Brain Tumors by 70% Without Toxicity
Landmark preclinical study shows intranasal ivermectin nanocapsules safely shrink glioblastoma in animal models at doses lower than the approved human antiparasitic dose 👇
📍Rats with implanted glioblastoma tumors received intranasal nano-ivermectin for 10 days at 60 µg/day — a dose below the approved human antiparasitic level.
📉Tumor volume dropped by ≈70% compared to untreated controls (79 mm³ vs 254–277 mm³).
📉The treatment also reduced necrosis, edema, and vascular proliferation, indicating less invasive and aggressive tumors.
✅No toxicity was observed — normal liver, kidney, blood, and lung histology; body weight unchanged throughout treatment.
Other formulations — free ivermectin and silica-based particles — showed no significant tumor reduction, highlighting key role of nanocapsule delivery for brain targeting.
These findings align with ivermectin’s 14 distinct anti-cancer mechanisms summarized by Yuwen et al, encompassing inhibition of oncogenic signaling (YAP1, Wnt–TCF, Akt/mTOR, EGFR/NF-κB, MAPK), mitochondrial and oxidative-stress induction, ion-channel modulation, and suppression of both cancer stem cells and the epithelial–mesenchymal transition (EMT).
Clinical translation in humans is urgently needed.
Landmark preclinical study shows intranasal ivermectin nanocapsules safely shrink glioblastoma in animal models at doses lower than the approved human antiparasitic dose 👇
📍Rats with implanted glioblastoma tumors received intranasal nano-ivermectin for 10 days at 60 µg/day — a dose below the approved human antiparasitic level.
📉Tumor volume dropped by ≈70% compared to untreated controls (79 mm³ vs 254–277 mm³).
📉The treatment also reduced necrosis, edema, and vascular proliferation, indicating less invasive and aggressive tumors.
✅No toxicity was observed — normal liver, kidney, blood, and lung histology; body weight unchanged throughout treatment.
Other formulations — free ivermectin and silica-based particles — showed no significant tumor reduction, highlighting key role of nanocapsule delivery for brain targeting.
These findings align with ivermectin’s 14 distinct anti-cancer mechanisms summarized by Yuwen et al, encompassing inhibition of oncogenic signaling (YAP1, Wnt–TCF, Akt/mTOR, EGFR/NF-κB, MAPK), mitochondrial and oxidative-stress induction, ion-channel modulation, and suppression of both cancer stem cells and the epithelial–mesenchymal transition (EMT).
Clinical translation in humans is urgently needed.
2
1. The Remarkable Anti-Cancer Potential of Mushrooms: thefocalpoints.com/p/the-remarkab…
2. Fenbendazole Linked to Remission in Three Stage IV Cancer Patients: thefocalpoints.com/p/new-study-fe…
3. Ivermectin Shows Striking Anticancer Potential and Remarkable Safety: thefocalpoints.com/p/new-study-iv…
2. Fenbendazole Linked to Remission in Three Stage IV Cancer Patients: thefocalpoints.com/p/new-study-fe…
3. Ivermectin Shows Striking Anticancer Potential and Remarkable Safety: thefocalpoints.com/p/new-study-iv…
